Junshi Biosciences shareholder cuts stake, reduces capital by over 1%

Shanghai Junshi Biosciences Co., Ltd. announced that Shanghai Tanying Investment Partnership (LP), a shareholder holding more than 5% of the company's shares, has reduced its stake. The reduction involved 12,000,000 A shares through block trades, representing 1.1688% of the company's total share capital. The transactions occurred between September 5, 2025, and September 22, 2025, with prices ranging from RMB 43.13 to RMB 48.46 per share, totaling RMB 557,940,000.00.

Prior to the reduction, Shanghai Tanying held 71,459,326 A shares, accounting for 6.9602% of the total share capital. Following the reduction, its current shareholding stands at 59,459,326 shares, or 5.7914%. The initial plan permitted a reduction of no more than 2% of the total share capital.

The reduction was executed due to the maturity of the fund and liquidity arrangements of Shanghai Tanying. The company confirmed that the reduction was in compliance with relevant laws and regulations and was consistent with the previously disclosed plan and undertakings.